1. Home
  2. FINV vs IRWD Comparison

FINV vs IRWD Comparison

Compare FINV & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FinVolution Group

FINV

FinVolution Group

N/A

Current Price

$2.95

Market Cap

668.1M

Sector

Finance

ML Signal

N/A

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

N/A

Current Price

$4.38

Market Cap

578.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FINV
IRWD
Founded
2007
1998
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
668.1M
578.3M
IPO Year
2017
2009

Fundamental Metrics

Financial Performance
Metric
FINV
IRWD
Price
$2.95
$4.38
Analyst Decision
Strong Buy
Buy
Analyst Count
6
4
Target Price
$5.62
★ $6.10
AVG Volume (30 Days)
866.5K
★ 1.6M
Earning Date
11-18-2026
11-05-2026
Dividend Yield
★ 10.55%
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ 0.91
Revenue
N/A
★ $298,276,000.00
Revenue This Year
N/A
$59.19
Revenue Next Year
N/A
$4.80
P/E Ratio
★ $3.87
$7.00
Revenue Growth
N/A
★ 8.88
52 Week Low
$2.80
$2.31
52 Week High
$6.39
$5.78

Technical Indicators

Market Signals
Indicator
FINV
IRWD
Relative Strength Index (RSI) 47.43 69.47
Support Level $2.89 $3.99
Resistance Level $3.25 $4.53
Average True Range (ATR) 0.15 0.20
MACD 0.02 0.10
Stochastic Oscillator 59.02 95.75

Price Performance

Historical Comparison
FINV
IRWD

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: